99mTc-TRODAT-1 SPECT 显示健康台湾人中晚期中年期纹状体多巴胺转运体可利用性显著下降后保持稳定
本研究纳入50名健康台湾成人(平均年龄63±12岁,范围30-80岁),使用kit法制备的99mTc-TRODAT-1进行纹状体多巴胺转运体(DAT)SPECT显像,以枕叶皮质为参考区计算特异性结合比。结果显示年龄对纹状体DAT有显著中至大负效应,30至80岁间下降-25.7%±6.10%,相当于每十年损失6.4%;尾状核和壳核每十年分别下降6.9%和7.3%。作者认为族裔差异可能不明显影响DAT的年龄相关下降,数据可作为参考用于估计DAT相关疾病患者的DAT损失/占据。
要点
- 健康台湾成人30至80岁纹状体DAT下降-25.7%±6.10%,相当于每十年损失6.4%。
- 尾状核每十年下降6.9%,壳核每十年下降7.3%。
- 作者认为族裔差异可能不明显影响DAT的年龄相关下降。
核心结论
- 本研究提示族裔差异可能不明显影响DAT的年龄相关下降,数据可作为参考用于估计DAT相关疾病患者的DAT损失/占据。
研究设计与样本
- 研究纳入50名健康受试者(平均年龄±标准差63±12岁,范围30-80岁),使用kit法制备的99mTc-TRODAT-1进行脑DAT SPECT显像。
- 注射后165至195分钟采集图像,注射剂量约740 MBq或20 mCi,使用配备扇束准直器的双探头相机(Helix SPX;GE)。
- 在纹状体最大活性层面的重建横断面上计算纹状体(ST)、尾状核(CA)和壳核(PU)的特异性摄取,以枕叶皮质为参考区,数据以特异性结合比表示。
主要发现
- 年龄对纹状体DAT有显著中至大负效应,30至80岁间下降-25.7%±6.10%,相当于每十年损失6.4%。
- 尾状核和壳核的下降速率分别为每十年6.9%和7.3%。
临床怎么用
- 作者认为本研究所生成的数据可作为参考,用于估计DAT相关疾病患者的DAT损失/占据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Neuroimaging studies in the past 20 years have documented an age-related decline in striatal dopamine transporters (DATs), which is a marker of dopaminergic neurodegeneration; however, concerns about ethnic variations in the decline in DAT with age have not been addressed. The purpose of this study was to assess the rate of striatal DAT loss in healthy Taiwanese adults using kit-based 99mTc-TRODAT-1, a radioligand for DAT SPECT. PATIENTS AND METHODS: Fifty healthy subjects (mean age ± SD, 63 ± 12 years; range, 30-80 years) were studied. 99mTc-TRODAT-1 was prepared from a lyophilized kit. Brain DAT SPECT imaging was acquired between 165 and 195 minutes postinjection (~740 MBq or 20 mCi) using a dual-head camera equipped with fan-beam collimators (Helix SPX; GE). Specific uptake in the striatum (ST), caudate nucleus (CA), and putamen (PU) were calculated from reconstructed transaxial slices at the level of maximal striatal activity. Occipital cortices were used as reference areas. Data were presented as specific binding ratios. RESULTS: Age had a significant moderate to large negative effect on striatal DAT, which declined by -25.7% ± 6.10% between the ages of 30 and 80 years, equivalent to 6.4% loss per decade. The rates of decline in the CA and PU were 6.9% and 7.3% per decade, respectively. CONCLUSIONS: This study suggests ethnic variations may not significantly affect the age-related decline in DAT. The data generated in this study could also be used as a reference to estimate DAT loss/occupancy in patients with DAT-related diseases.
引用
- Yeh SH, Tsai CJ, Yu TH, et al. 99mTc-TRODAT-1 SPECT Revealed That Striatal Dopamine Transport Availability Significantly Decreases in Late Mid-Aged Healthy Taiwanese and Then Remains Stable. Clin Nucl Med. 2022. PMID: 35081059. doi:10.1097/RLU.0000000000004063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。